Key result
Apo E ε4 allele is linked to ~2-fold higher odds of coronary artery disease.
Why the study?
The ε4 allele of the Apo E polymorphism has previously been associated with increased CAD, prompting investigation of its significance in the pathogenesis of CAD in Iranian patients with stenosis.
Does the Apo E gene polymorphism increase the risk of coronary artery disease with stenosis in an Iranian population?
Case-Control (n=200)
Does the Apo E gene polymorphism increase the risk of coronary artery disease with stenosis in an Iranian population?
In an Iranian case-control cohort, the Apo E ε4 allele was associated with a two-fold increased odds of angiographically significant coronary artery stenosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Apo E ε4 in Iranian CAD risk; prospective studies needed before clinical adoption.
The ε4 allele of the ε2, ε3 and ε4 protein isoform polymorphism in the gene encoding apolipoprotein E (Apo E) has previously been associated with increased cardiac artery disease (CAD); therefore to investigate the significance of this polymorphism in pathogenesis of CAD in Iranian patients with stenosis and control subjects. To investigate the association between Apo E polymorphism and coronary artery disease we performed a comparative case control study of the frequency of Apo E polymorphism in One hundred CAD patients with stenosis who underwent coronary angiography (>50% stenosis) and 100 control subjects (<10% stenosis). The Apo E alleles and genotypes were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). We observed an association between the Apo E polymorphism and CAD in this study. These data suggest that the Apo ε4 and ε2 alleles increase the risk for CAD in Iranian population (χ2 =4.26, p= 0.05, OR=2 and χ2 =0.38, p=0.53, OR=1.2). These results suggest that ε4 and ε2 alleles are risk factors for stenosis.
No takes yet. Share an insight, caveat, or question.
Fallah et al. (2009) conducted a case-control in Coronary artery disease (CAD) with stenosis (n=200). Apo E polymorphism (ε4 and ε2 alleles) vs. Control subjects (<10% stenosis) / non-risk alleles was evaluated on Coronary artery disease (>50% stenosis on coronary angiography) (OR 2, p=0.05). The Apo E ε4 allele was associated with an increased risk of coronary artery disease in an Iranian population, whereas the ε2 allele showed a non-significant association.
Synapse has enriched 10 related papers. Consider them for comparative context: